Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 11Recruiting 6Active not recruiting 5Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 4Other hematologic neoplasm 2Head & Neck 2Other 1Lymphoid 1Gynecologic 1Genitourinary 1Endocrine 1Breast 1

Conditions

Obesity 56Mucositis 22Polycystic Ovary Syndrome 20Neoplasms 17Sexual Dysfunction, Physiological 15Breast Neoplasms 14Dyspnea 11Head and Neck Neoplasms 10Motor Activity 8Colorectal Neoplasms 8Rectal Neoplasms 6Prostatic Neoplasms 6Diabetes Mellitus 6Stomatitis 5Pain 5Lung Neoplasms 5Constipation 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Obesity, Morbid 4Infertility 4Depression 4Colonic Neoplasms 4Xerostomia 3Weight Loss 3Pulmonary Disease, Chronic Obstructive 3Osteoporosis 3Metabolic Syndrome 3Insulin Resistance 3Heart Failure 3Eczema 3

Interventions

Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Diabetes Mellitus, Type 2 × Other × Clear all
NCT00038727 2021-12-28

DPPOS

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 3 Unknown
2,779 enrolled 16 charts
Other

Diabetes Mellitus, Diabetes Mellitus, Type 2, Neoplasms, Obesity, Prediabetic State

Data powered by HemOnc (CC BY 4.0) Colophon âš¡